Resmetirom improves liver fibrosis in nonalcoholic steatohepatitis
1. In this randomized controlled trial, among patients with nonalcoholic steatohepatitis (NASH) with liver fibrosis, resmetirom was superior to placebo ...
Tag: resmetirom
#VisualAbstract: Resmetirom improves outcomes in patients with nonalcoholic steatohepatitis (NASH) compared to placebo
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without ...